Start Date
July 12, 2018
Primary Completion Date
May 3, 2019
Study Completion Date
May 3, 2019
GSK3039294
GSK3039294 capsules will be available with a dose strength of 100 mg and 200 mg to be taken as single or multiple capsules orally along with water depending on the dosage required.
Placebo
Matching placebo capsules to match active 100 mg and 200 mg dose strength will be available and to be taken as single or multiple capsules orally along with water depending on the number of active capsules to blind.
GSK Investigational Site, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY